Share Price and Basic Stock Data
Last Updated: December 10, 2025, 11:08 pm
| PEG Ratio | -2.86 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Black Rose Industries Ltd operates in the specialty chemicals sector, a segment often characterized by its resilience and growth potential. As of the latest reporting period, the company recorded a market capitalization of ₹497 Cr, with its stock priced at ₹97.4. Revenue trends have shown some volatility, particularly over the past few quarters. For instance, sales peaked at ₹134.50 Cr in March 2022 but declined to ₹87.62 Cr by June 2023 before recovering slightly to ₹93.62 Cr in December 2023. The trailing twelve months (TTM) revenue stood at ₹353 Cr, reflecting a decline from ₹488 Cr in FY 2022. Such fluctuations may be indicative of market conditions, competitive pressures, or operational challenges, which investors should monitor closely.
Profitability and Efficiency Metrics
Profitability metrics for Black Rose Industries display a mixed performance. The company recorded a net profit of ₹20 Cr, translating to a net profit margin of approximately 5.35%. This is a decline from higher margins in previous years, such as 6.53% in FY 2022. Operating profit margins (OPM) have shown some recovery, rising to 10.29% as of March 2025, signaling improved operational efficiency. However, the return on equity (ROE) at 14.2% and return on capital employed (ROCE) of 19.0% suggest that while profitability is present, it may not be as robust as seen in earlier periods. The interest coverage ratio stands at an impressive 32.70x, indicating that the company can comfortably meet its interest obligations, which is a positive sign for investors.
Balance Sheet Strength and Financial Ratios
Examining the balance sheet, Black Rose Industries appears to maintain a strong financial position with total borrowings at just ₹8 Cr against reserves of ₹150 Cr, indicating minimal leverage. The current ratio of 2.97x suggests that the company has ample liquidity to cover its short-term obligations. Moreover, the debt-to-equity ratio remains low at 0.07, reinforcing the company’s conservative financing strategy. However, the cash conversion cycle (CCC) has stretched to 99 days, which could pose liquidity challenges if not managed effectively. Investors should be aware that while the balance sheet shows strength, the longer CCC may indicate inefficiencies in inventory management or receivables collection.
Shareholding Pattern and Investor Confidence
Black Rose Industries has a stable shareholding pattern, with promoters holding a substantial 75% stake. This level of promoter ownership often signals strong alignment with shareholder interests. Notably, foreign institutional investors (FIIs) have shown no significant presence, while domestic institutional investors (DIIs) hold just 0.07%. Public shareholding stands at 24.94%, which reflects a healthy level of retail participation. However, the declining number of shareholders from 79,251 in December 2022 to 52,795 by March 2025 raises questions about investor confidence. A decreasing shareholder base could indicate that while the core promoters are committed, broader market sentiment may not be as favorable, warranting further scrutiny.
Outlook, Risks, and Final Insight
Looking ahead, the outlook for Black Rose Industries hinges on its ability to navigate the challenges of a fluctuating market while capitalizing on growth opportunities in the specialty chemicals sector. Key strengths include a strong balance sheet with minimal debt and a high interest coverage ratio, which provide stability. However, risks are present; the declining profitability margins and the extended cash conversion cycle could impact liquidity and operational performance. Investors should remain vigilant about these factors, as they could influence future stock performance. The company’s ability to enhance operational efficiency and maintain shareholder confidence will be pivotal in shaping its trajectory. As with any investment, weighing these strengths against the potential risks will be crucial for informed decision-making.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Black Rose Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 391 Cr. | 42.6 | 83.5/41.2 | 24.3 | 20.5 | 0.94 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 30.7 Cr. | 62.5 | 99.5/56.0 | 14.7 | 89.6 | 1.60 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 43.2 Cr. | 634 | 960/600 | 19.9 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,539 Cr. | 78.0 | 111/74.5 | 23.4 | 22.0 | 0.64 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 643 Cr. | 258 | 453/241 | 23.1 | 93.8 | 0.97 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,710.04 Cr | 715.69 | 65.84 | 183.02 | 0.45% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 134.50 | 119.83 | 101.94 | 97.50 | 111.17 | 87.62 | 83.86 | 93.62 | 115.36 | 98.27 | 123.33 | 86.71 | 82.89 |
| Expenses | 126.39 | 113.44 | 98.76 | 96.32 | 108.13 | 81.99 | 75.87 | 86.34 | 108.20 | 92.09 | 116.63 | 78.90 | 74.36 |
| Operating Profit | 8.11 | 6.39 | 3.18 | 1.18 | 3.04 | 5.63 | 7.99 | 7.28 | 7.16 | 6.18 | 6.70 | 7.81 | 8.53 |
| OPM % | 6.03% | 5.33% | 3.12% | 1.21% | 2.73% | 6.43% | 9.53% | 7.78% | 6.21% | 6.29% | 5.43% | 9.01% | 10.29% |
| Other Income | 0.47 | 0.30 | 0.43 | 0.52 | 0.79 | 0.74 | 1.09 | 1.09 | 1.67 | 1.04 | 0.83 | 0.96 | 0.43 |
| Interest | 0.14 | 0.22 | 0.63 | 0.51 | 0.48 | 0.19 | 0.25 | 0.19 | 0.44 | 0.07 | 0.24 | 0.30 | 0.39 |
| Depreciation | 0.65 | 0.68 | 0.79 | 0.78 | 0.79 | 0.76 | 0.73 | 0.77 | 0.75 | 0.78 | 0.79 | 0.79 | 0.78 |
| Profit before tax | 7.79 | 5.79 | 2.19 | 0.41 | 2.56 | 5.42 | 8.10 | 7.41 | 7.64 | 6.37 | 6.50 | 7.68 | 7.79 |
| Tax % | 26.44% | 26.08% | 29.22% | 34.15% | 29.30% | 25.28% | 25.43% | 26.59% | 25.52% | 25.90% | 27.54% | 25.65% | 25.29% |
| Net Profit | 5.73 | 4.28 | 1.55 | 0.27 | 1.81 | 4.05 | 6.04 | 5.44 | 5.70 | 4.72 | 4.71 | 5.70 | 5.81 |
| EPS in Rs | 1.12 | 0.84 | 0.30 | 0.05 | 0.35 | 0.79 | 1.18 | 1.07 | 1.12 | 0.93 | 0.92 | 1.12 | 1.14 |
Last Updated: May 31, 2025, 6:41 am
Below is a detailed analysis of the quarterly data for Black Rose Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 82.89 Cr.. The value appears to be declining and may need further review. It has decreased from 86.71 Cr. (Dec 2024) to 82.89 Cr., marking a decrease of 3.82 Cr..
- For Expenses, as of Mar 2025, the value is 74.36 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 78.90 Cr. (Dec 2024) to 74.36 Cr., marking a decrease of 4.54 Cr..
- For Operating Profit, as of Mar 2025, the value is 8.53 Cr.. The value appears strong and on an upward trend. It has increased from 7.81 Cr. (Dec 2024) to 8.53 Cr., marking an increase of 0.72 Cr..
- For OPM %, as of Mar 2025, the value is 10.29%. The value appears strong and on an upward trend. It has increased from 9.01% (Dec 2024) to 10.29%, marking an increase of 1.28%.
- For Other Income, as of Mar 2025, the value is 0.43 Cr.. The value appears to be declining and may need further review. It has decreased from 0.96 Cr. (Dec 2024) to 0.43 Cr., marking a decrease of 0.53 Cr..
- For Interest, as of Mar 2025, the value is 0.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.30 Cr. (Dec 2024) to 0.39 Cr., marking an increase of 0.09 Cr..
- For Depreciation, as of Mar 2025, the value is 0.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.79 Cr. (Dec 2024) to 0.78 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Mar 2025, the value is 7.79 Cr.. The value appears strong and on an upward trend. It has increased from 7.68 Cr. (Dec 2024) to 7.79 Cr., marking an increase of 0.11 Cr..
- For Tax %, as of Mar 2025, the value is 25.29%. The value appears to be improving (decreasing) as expected. It has decreased from 25.65% (Dec 2024) to 25.29%, marking a decrease of 0.36%.
- For Net Profit, as of Mar 2025, the value is 5.81 Cr.. The value appears strong and on an upward trend. It has increased from 5.70 Cr. (Dec 2024) to 5.81 Cr., marking an increase of 0.11 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.14. The value appears strong and on an upward trend. It has increased from 1.12 (Dec 2024) to 1.14, marking an increase of 0.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 115 | 196 | 177 | 242 | 298 | 309 | 373 | 380 | 488 | 430 | 380 | 391 | 353 |
| Expenses | 113 | 189 | 168 | 227 | 276 | 284 | 340 | 339 | 442 | 416 | 352 | 362 | 324 |
| Operating Profit | 2 | 7 | 10 | 15 | 22 | 24 | 33 | 40 | 46 | 14 | 28 | 29 | 29 |
| OPM % | 2% | 3% | 5% | 6% | 7% | 8% | 9% | 11% | 9% | 3% | 7% | 8% | 8% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | -0 | 1 | 1 | 2 | 5 | 3 | 3 |
| Interest | 3 | 5 | 5 | 5 | 4 | 4 | 3 | 2 | 1 | 2 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | -2 | -1 | 2 | 8 | 16 | 19 | 27 | 37 | 43 | 11 | 29 | 28 | 28 |
| Tax % | 11% | -177% | 35% | 34% | 27% | 28% | 24% | 25% | 26% | 28% | 26% | 26% | |
| Net Profit | -3 | 1 | 2 | 5 | 12 | 14 | 21 | 27 | 32 | 8 | 21 | 21 | 20 |
| EPS in Rs | -0.53 | 0.10 | 0.32 | 0.98 | 2.30 | 2.72 | 4.05 | 5.38 | 6.25 | 1.55 | 4.16 | 4.11 | 4.00 |
| Dividend Payout % | 0% | 0% | 0% | 10% | 7% | 11% | 9% | 8% | 12% | 35% | 16% | 77% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 133.33% | 100.00% | 150.00% | 140.00% | 16.67% | 50.00% | 28.57% | 18.52% | -75.00% | 162.50% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -33.33% | 50.00% | -10.00% | -123.33% | 33.33% | -21.43% | -10.05% | -93.52% | 237.50% | -162.50% |
Black Rose Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 1% |
| 3 Years: | -7% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 43% |
| 5 Years: | 0% |
| 3 Years: | -13% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | -5% |
| 3 Years: | -20% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 18% |
| 3 Years: | 12% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 14 | 14 | 16 | 20 | 30 | 43 | 62 | 88 | 117 | 122 | 140 | 148 | 150 |
| Borrowings | 37 | 42 | 42 | 42 | 35 | 30 | 23 | 17 | 14 | 5 | 4 | 11 | 8 |
| Other Liabilities | 34 | 30 | 22 | 42 | 34 | 31 | 51 | 37 | 40 | 30 | 43 | 50 | 50 |
| Total Liabilities | 90 | 92 | 84 | 109 | 105 | 109 | 141 | 147 | 176 | 162 | 193 | 214 | 213 |
| Fixed Assets | 42 | 41 | 38 | 36 | 34 | 33 | 37 | 35 | 37 | 40 | 41 | 39 | 46 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 8 | 8 | 7 | 9 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 10 |
| Other Assets | 48 | 51 | 46 | 73 | 71 | 76 | 102 | 105 | 130 | 114 | 132 | 166 | 152 |
| Total Assets | 90 | 92 | 84 | 109 | 105 | 109 | 141 | 147 | 176 | 162 | 193 | 214 | 213 |
Below is a detailed analysis of the balance sheet data for Black Rose Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 150.00 Cr.. The value appears strong and on an upward trend. It has increased from 148.00 Cr. (Mar 2025) to 150.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 11.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 50.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 50.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 213.00 Cr.. The value appears to be improving (decreasing). It has decreased from 214.00 Cr. (Mar 2025) to 213.00 Cr., marking a decrease of 1.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 152.00 Cr.. The value appears to be declining and may need further review. It has decreased from 166.00 Cr. (Mar 2025) to 152.00 Cr., marking a decrease of 14.00 Cr..
- For Total Assets, as of Sep 2025, the value is 213.00 Cr.. The value appears to be declining and may need further review. It has decreased from 214.00 Cr. (Mar 2025) to 213.00 Cr., marking a decrease of 1.00 Cr..
Notably, the Reserves (150.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -35.00 | -35.00 | -32.00 | -27.00 | -13.00 | -6.00 | 10.00 | 23.00 | 32.00 | 9.00 | 24.00 | 18.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 52 | 47 | 52 | 42 | 33 | 47 | 42 | 50 | 50 | 64 | 63 |
| Inventory Days | 66 | 32 | 35 | 43 | 37 | 46 | 45 | 53 | 41 | 28 | 44 | 81 |
| Days Payable | 102 | 57 | 41 | 59 | 38 | 34 | 52 | 34 | 28 | 20 | 40 | 45 |
| Cash Conversion Cycle | 34 | 28 | 41 | 37 | 41 | 45 | 40 | 61 | 63 | 58 | 69 | 99 |
| Working Capital Days | -17 | -3 | 4 | 11 | 16 | 28 | 29 | 48 | 53 | 54 | 67 | 93 |
| ROCE % | 1% | 8% | 12% | 19% | 29% | 31% | 38% | 38% | 36% | 10% | 21% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| Diluted EPS (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| Cash EPS (Rs.) | 4.72 | 4.75 | 2.15 | 6.77 | 5.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.97 | 28.45 | 24.92 | 23.99 | 18.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.97 | 28.45 | 24.92 | 23.99 | 18.23 |
| Revenue From Operations / Share (Rs.) | 76.71 | 74.59 | 84.40 | 95.66 | 74.47 |
| PBDIT / Share (Rs.) | 6.42 | 6.40 | 3.10 | 9.12 | 7.96 |
| PBIT / Share (Rs.) | 5.80 | 5.81 | 2.51 | 8.60 | 7.45 |
| PBT / Share (Rs.) | 5.56 | 5.60 | 2.15 | 8.43 | 7.21 |
| Net Profit / Share (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| NP After MI And SOA / Share (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| PBDIT Margin (%) | 8.36 | 8.58 | 3.67 | 9.53 | 10.68 |
| PBIT Margin (%) | 7.56 | 7.79 | 2.97 | 8.99 | 10.00 |
| PBT Margin (%) | 7.24 | 7.51 | 2.54 | 8.81 | 9.68 |
| Net Profit Margin (%) | 5.35 | 5.58 | 1.83 | 6.53 | 7.22 |
| NP After MI And SOA Margin (%) | 5.35 | 5.58 | 1.83 | 6.53 | 7.22 |
| Return on Networth / Equity (%) | 13.70 | 14.63 | 6.23 | 26.07 | 29.51 |
| Return on Capital Employeed (%) | 18.62 | 19.54 | 9.51 | 33.79 | 37.87 |
| Return On Assets (%) | 9.77 | 11.02 | 4.88 | 18.15 | 18.66 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Total Debt / Equity (X) | 0.07 | 0.02 | 0.03 | 0.11 | 0.17 |
| Asset Turnover Ratio (%) | 1.92 | 2.15 | 2.55 | 2.17 | 1.66 |
| Current Ratio (X) | 2.97 | 3.48 | 4.04 | 2.83 | 2.24 |
| Quick Ratio (X) | 1.68 | 2.54 | 2.98 | 1.82 | 1.27 |
| Inventory Turnover Ratio (X) | 7.12 | 11.20 | 1.50 | 1.53 | 0.99 |
| Dividend Payout Ratio (NP) (%) | 64.52 | 13.21 | 48.30 | 7.19 | 6.50 |
| Dividend Payout Ratio (CP) (%) | 56.10 | 11.57 | 34.91 | 6.64 | 5.94 |
| Earning Retention Ratio (%) | 35.48 | 86.79 | 51.70 | 92.81 | 93.50 |
| Cash Earning Retention Ratio (%) | 43.90 | 88.43 | 65.09 | 93.36 | 94.06 |
| Interest Coverage Ratio (X) | 32.70 | 30.57 | 8.61 | 52.25 | 33.69 |
| Interest Coverage Ratio (Post Tax) (X) | 22.17 | 20.87 | 5.31 | 36.84 | 23.79 |
| Enterprise Value (Cr.) | 457.39 | 609.04 | 526.75 | 997.89 | 894.77 |
| EV / Net Operating Revenue (X) | 1.17 | 1.60 | 1.22 | 2.05 | 2.36 |
| EV / EBITDA (X) | 13.97 | 18.65 | 33.29 | 21.46 | 22.05 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.64 | 1.26 | 2.04 | 2.33 |
| Retention Ratios (%) | 35.47 | 86.78 | 51.69 | 92.80 | 93.49 |
| Price / BV (X) | 2.98 | 4.30 | 4.26 | 8.15 | 9.54 |
| Price / Net Operating Revenue (X) | 1.16 | 1.64 | 1.26 | 2.04 | 2.33 |
| EarningsYield | 0.04 | 0.03 | 0.01 | 0.03 | 0.03 |
After reviewing the key financial ratios for Black Rose Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.72. This value is within the healthy range. It has decreased from 4.75 (Mar 24) to 4.72, marking a decrease of 0.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 28.45 (Mar 24) to 29.97, marking an increase of 1.52.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 28.45 (Mar 24) to 29.97, marking an increase of 1.52.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 76.71. It has increased from 74.59 (Mar 24) to 76.71, marking an increase of 2.12.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 6.42, marking an increase of 0.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has decreased from 5.81 (Mar 24) to 5.80, marking a decrease of 0.01.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.56. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 5.56, marking a decrease of 0.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For PBDIT Margin (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 10. It has decreased from 8.58 (Mar 24) to 8.36, marking a decrease of 0.22.
- For PBIT Margin (%), as of Mar 25, the value is 7.56. This value is below the healthy minimum of 10. It has decreased from 7.79 (Mar 24) to 7.56, marking a decrease of 0.23.
- For PBT Margin (%), as of Mar 25, the value is 7.24. This value is below the healthy minimum of 10. It has decreased from 7.51 (Mar 24) to 7.24, marking a decrease of 0.27.
- For Net Profit Margin (%), as of Mar 25, the value is 5.35. This value is within the healthy range. It has decreased from 5.58 (Mar 24) to 5.35, marking a decrease of 0.23.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 8. It has decreased from 5.58 (Mar 24) to 5.35, marking a decrease of 0.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.70. This value is below the healthy minimum of 15. It has decreased from 14.63 (Mar 24) to 13.70, marking a decrease of 0.93.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.62. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 18.62, marking a decrease of 0.92.
- For Return On Assets (%), as of Mar 25, the value is 9.77. This value is within the healthy range. It has decreased from 11.02 (Mar 24) to 9.77, marking a decrease of 1.25.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.07, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.92. It has decreased from 2.15 (Mar 24) to 1.92, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 2.97. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.97, marking a decrease of 0.51.
- For Quick Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 2.54 (Mar 24) to 1.68, marking a decrease of 0.86.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.12. This value is within the healthy range. It has decreased from 11.20 (Mar 24) to 7.12, marking a decrease of 4.08.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 64.52. This value exceeds the healthy maximum of 50. It has increased from 13.21 (Mar 24) to 64.52, marking an increase of 51.31.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 56.10. This value exceeds the healthy maximum of 50. It has increased from 11.57 (Mar 24) to 56.10, marking an increase of 44.53.
- For Earning Retention Ratio (%), as of Mar 25, the value is 35.48. This value is below the healthy minimum of 40. It has decreased from 86.79 (Mar 24) to 35.48, marking a decrease of 51.31.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 43.90. This value is within the healthy range. It has decreased from 88.43 (Mar 24) to 43.90, marking a decrease of 44.53.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 32.70. This value is within the healthy range. It has increased from 30.57 (Mar 24) to 32.70, marking an increase of 2.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 22.17. This value is within the healthy range. It has increased from 20.87 (Mar 24) to 22.17, marking an increase of 1.30.
- For Enterprise Value (Cr.), as of Mar 25, the value is 457.39. It has decreased from 609.04 (Mar 24) to 457.39, marking a decrease of 151.65.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.17, marking a decrease of 0.43.
- For EV / EBITDA (X), as of Mar 25, the value is 13.97. This value is within the healthy range. It has decreased from 18.65 (Mar 24) to 13.97, marking a decrease of 4.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.16, marking a decrease of 0.48.
- For Retention Ratios (%), as of Mar 25, the value is 35.47. This value is within the healthy range. It has decreased from 86.78 (Mar 24) to 35.47, marking a decrease of 51.31.
- For Price / BV (X), as of Mar 25, the value is 2.98. This value is within the healthy range. It has decreased from 4.30 (Mar 24) to 2.98, marking a decrease of 1.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.16, marking a decrease of 0.48.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Black Rose Industries Ltd:
- Net Profit Margin: 5.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.62% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.7% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 22.17
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.68
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.4 (Industry average Stock P/E: 65.84)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.35%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 145-A, Mittal Tower, Mumbai Maharashtra 400021 | investor@blackrosechemicals.com http://www.blackrosechemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anup Jatia | Non Executive Chairperson |
| Mrs. Shruti Jatia | Whole Time Director |
| Mr. Ambarish Daga | Whole Time Director |
| Mr. Rishabh Saraf | Ind. Non-Executive Director |
| Mr. Abhishek Murarka | Ind. Non-Executive Director |
| Mrs. Deepa Poncha | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Black Rose Industries Ltd?
Black Rose Industries Ltd's intrinsic value (as of 11 December 2025) is 85.45 which is 12.45% lower the current market price of 97.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 498 Cr. market cap, FY2025-2026 high/low of 138/87.0, reserves of ₹150 Cr, and liabilities of 213 Cr.
What is the Market Cap of Black Rose Industries Ltd?
The Market Cap of Black Rose Industries Ltd is 498 Cr..
What is the current Stock Price of Black Rose Industries Ltd as on 11 December 2025?
The current stock price of Black Rose Industries Ltd as on 11 December 2025 is 97.6.
What is the High / Low of Black Rose Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Black Rose Industries Ltd stocks is 138/87.0.
What is the Stock P/E of Black Rose Industries Ltd?
The Stock P/E of Black Rose Industries Ltd is 24.4.
What is the Book Value of Black Rose Industries Ltd?
The Book Value of Black Rose Industries Ltd is 30.5.
What is the Dividend Yield of Black Rose Industries Ltd?
The Dividend Yield of Black Rose Industries Ltd is 1.08 %.
What is the ROCE of Black Rose Industries Ltd?
The ROCE of Black Rose Industries Ltd is 19.0 %.
What is the ROE of Black Rose Industries Ltd?
The ROE of Black Rose Industries Ltd is 14.2 %.
What is the Face Value of Black Rose Industries Ltd?
The Face Value of Black Rose Industries Ltd is 1.00.